• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Neurodegenerative Disease Treatment Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Drug Class and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Neurodegenerative Disease Treatment Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Neurodegenerative Disease Treatment Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Neurodegenerative Disease Treatment Market Size & Forecast:

Global Neurodegenerative Disease Treatment market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Neurodegenerative Disease Treatment Market Segmentation:

The research offers a comprehensive analysis of global Neurodegenerative Disease Treatment market with respect to following sub-markets:

Based on Drug Class:
- NMDA Receptor
- Dopamine Inhibitors
- Cholinesterase Inhibitors
- SSRI Inhibitor
- Others

Based on Disease:
- Parkinson’s Disease
- Huntington’s Disease
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Others

Based on Distribution Channel:
- Hospitals
- Online Pharmacies
- Retail Pharmacies

Global Neurodegenerative Disease Treatment Market: Competitive Landscape

The report also highlights the competitive landscape of the global Neurodegenerative Disease Treatment market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Drug Class development, research & development and other market activities).

The report includes profiles of leading companies in the global Neurodegenerative Disease Treatment market.

Some of the key players profiled include:

- Novartis AG
- Pfizer Inc.
- Merck Serono
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB
- C.H. Boehringer Sohn AG & Ko. KG
- Sanofi S.A.
- GlaxoSmithKline
- Neuro-Hitech Inc.
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Neurodegenerative Disease Treatment Industry Report:

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Neurodegenerative Disease Treatment Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of Neurodegenerative Disease Treatment
4.3. Manufacturing Process Analysis of Neurodegenerative Disease Treatment
4.4. Manufacturing Cost Structure Analysis of Neurodegenerative Disease Treatment

5. Manufacturing Plants Analysis of Neurodegenerative Disease Treatment

5.1. Capacity and Production
5.2. Global Neurodegenerative Disease Treatment Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. Global Neurodegenerative Disease Treatment Market 2018
6.2. Global Neurodegenerative Disease Treatment Market Value Share, By Company 2018
6.3. Global Neurodegenerative Disease Treatment Market Volume Share, By Company 2018

7. Market Dynamics

7.1. Growth Drivers & Barriers in Neurodegenerative Disease Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in Neurodegenerative Disease Market

8. Global Neurodegenerative Disease Treatment Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. Global Neurodegenerative Disease Treatment Market Segmentation Analysis, By Drug Class

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Drug Class
9.2.2. Market Attractiveness, By Drug Class
9.3. NMDA Receptor
9.3.1. Key Trends & Growth Drivers
9.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Dopamine Inhibitors
9.4.1. Key Trends & Growth Drivers
9.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Cholinesterase Inhibitors
9.5.1. Key Trends & Growth Drivers
9.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6. SSRI Inhibitor
9.6.1. Key Trends & Growth Drivers
9.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7. Others
9.7.1. Key Trends & Growth Drivers
9.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Global Neurodegenerative Disease Treatment Market Segmentation Analysis, By Disease

10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Disease
10.2.2. Market Attractiveness, By Disease
10.3. Parkinson’s Disease
10.3.1. Key Trends & Growth Drivers
10.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Huntington’s Disease
10.4.1. Key Trends & Growth Drivers
10.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5. Alzheimer’s Disease
10.5.1. Key Trends & Growth Drivers
10.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.6. Amyotrophic Lateral Sclerosis
10.6.1. Key Trends & Growth Drivers
10.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.7. Others
10.7.1. Key Trends & Growth Drivers
10.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11. Global Neurodegenerative Disease Treatment Market Segmentation Analysis, By Distribution Channel

11.1. Introduction
11.2. Strategic Insights
11.2.1. BPS Analysis, By Distribution Channel
11.2.2. Market Attractiveness, By Distribution Channel
11.3. Hospitals
11.3.1. Key Trends & Growth Drivers
11.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4. Online Pharmacies
11.4.1. Key Trends & Growth Drivers
11.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5. Retail Pharmacies
11.5.1. Key Trends & Growth Drivers
11.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12. Geographical Analysis

12.1. Introduction
12.2. North America Neurodegenerative Disease Treatment Market
12.2.1. Key Trends & Growth Drivers
12.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4. By Drug Class
12.2.4.1. Introduction
12.2.4.2. Strategic Insights
12.2.4.2.1. BPS Analysis, By Drug Class
12.2.4.2.2. Market Attractiveness, By Drug Class
12.2.4.3. NMDA Receptor
12.2.4.3.1. Key Trends & Growth Drivers
12.2.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4. Dopamine Inhibitors
12.2.4.4.1. Key Trends & Growth Drivers
12.2.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5. Cholinesterase Inhibitors
12.2.4.5.1. Key Trends & Growth Drivers
12.2.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.6. SSRI Inhibitor
12.2.4.6.1. Key Trends & Growth Drivers
12.2.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.7. Others
12.2.4.7.1. Key Trends & Growth Drivers
12.2.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5. By Disease
12.2.5.1. Introduction
12.2.5.2. Strategic Insights
12.2.5.2.1. BPS Analysis, By Disease
12.2.5.2.2. Market Attractiveness, By Disease
12.2.5.3. Parkinson’s Disease
12.2.5.3.1. Key Trends & Growth Drivers
12.2.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4. Huntington’s Disease
12.2.5.4.1. Key Trends & Growth Drivers
12.2.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.5. Alzheimer’s Disease
12.2.5.5.1. Key Trends & Growth Drivers
12.2.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.6. Amyotrophic Lateral Sclerosis
12.2.5.6.1. Key Trends & Growth Drivers
12.2.5.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.7. Others
12.2.5.7.1. Key Trends & Growth Drivers
12.2.5.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6. By Distribution Channel
12.2.6.1. Introduction
12.2.6.2. Strategic Insights
12.2.6.2.1. BPS Analysis, By Distribution Channel
12.2.6.2.2. Market Attractiveness, By Distribution Channel
12.2.6.3. Hospitals
12.2.6.3.1. Key Trends & Growth Drivers
12.2.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4. Online Pharmacies
12.2.6.4.1. Key Trends & Growth Drivers
12.2.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5. Retail Pharmacies
12.2.6.5.1. Key Trends & Growth Drivers
12.2.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7. By Country
12.2.7.1. Introduction
12.2.7.2. Strategic Insights
12.2.7.2.1. BPS Analysis, By Country
12.2.7.2.2. Market Attractiveness, By Country
12.2.7.3. U.S. Neurodegenerative Disease Treatment Market
12.2.7.3.1. Key Trends & Growth Drivers
12.2.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4. Canada Neurodegenerative Disease Treatment Market
12.2.7.4.1. Key Trends & Growth Drivers
12.2.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.3. Europe Neurodegenerative Disease Treatment Market

12.3.1. Key Trends & Growth Drivers
12.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4. By Drug Class
12.3.4.1. Introduction
12.3.4.2. Strategic Insights
12.3.4.2.1. BPS Analysis, By Drug Class
12.3.4.2.2. Market Attractiveness, By Drug Class
12.3.4.3. NMDA Receptor
12.3.4.3.1. Key Trends & Growth Drivers
12.3.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4. Dopamine Inhibitors
12.3.4.4.1. Key Trends & Growth Drivers
12.3.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5. Cholinesterase Inhibitors
12.3.4.5.1. Key Trends & Growth Drivers
12.3.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.6. SSRI Inhibitor
12.3.4.6.1. Key Trends & Growth Drivers
12.3.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.7. Others
12.3.4.7.1. Key Trends & Growth Drivers
12.3.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5. By Disease
12.3.5.1. Introduction
12.3.5.2. Strategic Insights
12.3.5.2.1. BPS Analysis, By Disease
12.3.5.2.2. Market Attractiveness, By Disease
12.3.5.3. Parkinson’s Disease
12.3.5.3.1. Key Trends & Growth Drivers
12.3.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4. Huntington’s Disease
12.3.5.4.1. Key Trends & Growth Drivers
12.3.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.5. Alzheimer’s Disease
12.3.5.5.1. Key Trends & Growth Drivers
12.3.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.6. Amyotrophic Lateral Sclerosis
12.3.5.6.1. Key Trends & Growth Drivers
12.3.5.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.7. Others
12.3.5.7.1. Key Trends & Growth Drivers
12.3.5.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6. By Distribution Channel
12.3.6.1. Introduction
12.3.6.2. Strategic Insights
12.3.6.2.1. BPS Analysis, By Distribution Channel
12.3.6.2.2. Market Attractiveness, By Distribution Channel
12.3.6.3. Hospitals
12.3.6.3.1. Key Trends & Growth Drivers
12.3.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4. Online Pharmacies
12.3.6.4.1. Key Trends & Growth Drivers
12.3.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5. Retail Pharmacies
12.3.6.5.1. Key Trends & Growth Drivers
12.3.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7. By Country
12.3.7.1. Introduction
12.3.7.2. Strategic Insights
12.3.7.2.1. BPS Analysis, By Country
12.3.7.2.2. Market Attractiveness, By Country
12.3.7.3. Germany Neurodegenerative Disease Treatment Market
12.3.7.3.1. Key Trends & Growth Drivers
12.3.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4. United Kingdom Neurodegenerative Disease Treatment Market
12.3.7.4.1. Key Trends & Growth Drivers
12.3.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5. France Neurodegenerative Disease Treatment Market
12.3.7.5.1. Key Trends & Growth Drivers
12.3.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6. Italy Neurodegenerative Disease Treatment Market
12.3.7.6.1. Key Trends & Growth Drivers
12.3.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7. Spain Neurodegenerative Disease Treatment Market
12.3.7.7.1. Key Trends & Growth Drivers
12.3.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8. Russia Neurodegenerative Disease Treatment Market
12.3.7.8.1. Key Trends & Growth Drivers
12.3.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.9. Rest of Europe Neurodegenerative Disease Treatment Market
12.3.7.9.1. Key Trends & Growth Drivers
12.3.7.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.4. Asia Pacific Neurodegenerative Disease Treatment Market

12.4.1. Key Trends & Growth Drivers
12.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4. By Drug Class
12.4.4.1. Introduction
12.4.4.2. Strategic Insights
12.4.4.2.1. BPS Analysis, By Drug Class
12.4.4.2.2. Market Attractiveness, By Drug Class
12.4.4.3. NMDA Receptor
12.4.4.3.1. Key Trends & Growth Drivers
12.4.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4. Dopamine Inhibitors
12.4.4.4.1. Key Trends & Growth Drivers
12.4.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5. Cholinesterase Inhibitors
12.4.4.5.1. Key Trends & Growth Drivers
12.4.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.6. SSRI Inhibitor
12.4.4.6.1. Key Trends & Growth Drivers
12.4.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.7. Others
12.4.4.7.1. Key Trends & Growth Drivers
12.4.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5. By Disease
12.4.5.1. Introduction
12.4.5.2. Strategic Insights
12.4.5.2.1. BPS Analysis, By Disease
12.4.5.2.2. Market Attractiveness, By Disease
12.4.5.3. Parkinson’s Disease
12.4.5.3.1. Key Trends & Growth Drivers
12.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4. Huntington’s Disease
12.4.5.4.1. Key Trends & Growth Drivers
12.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.5. Alzheimer’s Disease
12.4.5.5.1. Key Trends & Growth Drivers
12.4.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.6. Amyotrophic Lateral Sclerosis
12.4.5.6.1. Key Trends & Growth Drivers
12.4.5.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.7. Others
12.4.5.7.1. Key Trends & Growth Drivers
12.4.5.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6. By Distribution Channel
12.4.6.1. Introduction
12.4.6.2. Strategic Insights
12.4.6.2.1. BPS Analysis, By Distribution Channel
12.4.6.2.2. Market Attractiveness, By Distribution Channel
12.4.6.3. Hospitals
12.4.6.3.1. Key Trends & Growth Drivers
12.4.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4. Online Pharmacies
12.4.6.4.1. Key Trends & Growth Drivers
12.4.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5. Retail Pharmacies
12.4.6.5.1. Key Trends & Growth Drivers
12.4.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7. By Country
12.4.7.1. Introduction
12.4.7.2. Strategic Insights
12.4.7.2.1. BPS Analysis, By Country
12.4.7.2.2. Market Attractiveness, By Country
12.4.7.3. China Neurodegenerative Disease Treatment Market
12.4.7.3.1. Key Trends & Growth Drivers
12.4.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4. India Neurodegenerative Disease Treatment Market
12.4.7.4.1. Key Trends & Growth Drivers
12.4.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5. Japan Neurodegenerative Disease Treatment Market
12.4.7.5.1. Key Trends & Growth Drivers
12.4.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.6. South Korea Neurodegenerative Disease Treatment Market
12.4.7.6.1. Key Trends & Growth Drivers
12.4.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7. Indonesia Neurodegenerative Disease Treatment Market
12.4.7.7.1. Key Trends & Growth Drivers
12.4.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8. Taiwan Neurodegenerative Disease Treatment Market
12.4.7.8.1. Key Trends & Growth Drivers
12.4.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9. Australia Neurodegenerative Disease Treatment Market
12.4.7.9.1. Key Trends & Growth Drivers
12.4.7.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10. New Zealand Neurodegenerative Disease Treatment Market
12.4.7.10.1. Key Trends & Growth Drivers
12.4.7.10.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11. Rest of Asia Pacific Neurodegenerative Disease Treatment Market
12.4.7.11.1. Key Trends & Growth Drivers
12.4.7.11.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.5. Latin America Neurodegenerative Disease Treatment Market

12.5.1. Key Trends & Growth Drivers
12.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4. By Drug Class
12.5.4.1. Introduction
12.5.4.2. Strategic Insights
12.5.4.2.1. BPS Analysis, By Drug Class
12.5.4.2.2. Market Attractiveness, By Drug Class
12.5.4.3. NMDA Receptor
12.5.4.3.1. Key Trends & Growth Drivers
12.5.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4. Dopamine Inhibitors
12.5.4.4.1. Key Trends & Growth Drivers
12.5.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5. Cholinesterase Inhibitors
12.5.4.5.1. Key Trends & Growth Drivers
12.5.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.6. SSRI Inhibitor
12.5.4.6.1. Key Trends & Growth Drivers
12.5.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.7. Others
12.5.4.7.1. Key Trends & Growth Drivers
12.5.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5. By Disease
12.5.5.1. Introduction
12.5.5.2. Strategic Insights
12.5.5.2.1. BPS Analysis, By Disease
12.5.5.2.2. Market Attractiveness, By Disease
12.5.5.3. Parkinson’s Disease
12.5.5.3.1. Key Trends & Growth Drivers
12.5.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4. Huntington’s Disease
12.5.5.4.1. Key Trends & Growth Drivers
12.5.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.5. Alzheimer’s Disease
12.5.5.5.1. Key Trends & Growth Drivers
12.5.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.6. Amyotrophic Lateral Sclerosis
12.5.5.6.1. Key Trends & Growth Drivers
12.5.5.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.7. Others
12.5.5.7.1. Key Trends & Growth Drivers
12.5.5.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6. By Distribution Channel
12.5.6.1. Introduction
12.5.6.2. Strategic Insights
12.5.6.2.1. BPS Analysis, By Distribution Channel
12.5.6.2.2. Market Attractiveness, By Distribution Channel
12.5.6.3. Hospitals
12.5.6.3.1. Key Trends & Growth Drivers
12.5.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4. Online Pharmacies
12.5.6.4.1. Key Trends & Growth Drivers
12.5.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5. Retail Pharmacies
12.5.6.5.1. Key Trends & Growth Drivers
12.5.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7. By Country
12.5.7.1. Introduction
12.5.7.2. Strategic Insights
12.5.7.2.1. BPS Analysis, By Country
12.5.7.2.2. Market Attractiveness, By Country
12.5.7.3. Brazil Neurodegenerative Disease Treatment Market
12.5.7.3.1. Key Trends & Growth Drivers
12.5.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4. Mexico Neurodegenerative Disease Treatment Market
12.5.7.4.1. Key Trends & Growth Drivers
12.5.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5. Rest of Latin America Neurodegenerative Disease Treatment Market
12.5.7.5.1. Key Trends & Growth Drivers
12.5.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.6. Middle East & Africa Neurodegenerative Disease Treatment Market

12.6.1. Key Trends & Growth Drivers
12.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4. By Drug Class
12.6.4.1. Introduction
12.6.4.2. Strategic Insights
12.6.4.2.1. BPS Analysis, By Drug Class
12.6.4.2.2. Market Attractiveness, By Drug Class
12.6.4.3. NMDA Receptor
12.6.4.3.1. Key Trends & Growth Drivers
12.6.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4. Dopamine Inhibitors
12.6.4.4.1. Key Trends & Growth Drivers
12.6.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5. Cholinesterase Inhibitors
12.6.4.5.1. Key Trends & Growth Drivers
12.6.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.6. SSRI Inhibitor
12.6.4.6.1. Key Trends & Growth Drivers
12.6.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.7. Others
12.6.4.7.1. Key Trends & Growth Drivers
12.6.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5. By Disease
12.6.5.1. Introduction
12.6.5.2. Strategic Insights
12.6.5.2.1. BPS Analysis, By Disease
12.6.5.2.2. Market Attractiveness, By Disease
12.6.5.3. Parkinson’s Disease
12.6.5.3.1. Key Trends & Growth Drivers
12.6.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4. Huntington’s Disease
12.6.5.4.1. Key Trends & Growth Drivers
12.6.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.5. Alzheimer’s Disease
12.6.5.5.1. Key Trends & Growth Drivers
12.6.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.6. Amyotrophic Lateral Sclerosis
12.6.5.6.1. Key Trends & Growth Drivers
12.6.5.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.7. Others
12.6.5.7.1. Key Trends & Growth Drivers
12.6.5.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6. By Distribution Channel
12.6.6.1. Introduction
12.6.6.2. Strategic Insights
12.6.6.2.1. BPS Analysis, By Distribution Channel
12.6.6.2.2. Market Attractiveness, By Distribution Channel
12.6.6.3. Hospitals
12.6.6.3.1. Key Trends & Growth Drivers
12.6.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4. Online Pharmacies
12.6.6.4.1. Key Trends & Growth Drivers
12.6.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5. Retail Pharmacies
12.6.6.5.1. Key Trends & Growth Drivers
12.6.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7. By Geography
12.6.7.1. Introduction
12.6.7.2. Strategic Insights
12.6.7.2.1. BPS Analysis, By Geography
12.6.7.2.2. Market Attractiveness, By Geography
12.6.7.3. GCC Neurodegenerative Disease Treatment Market
12.6.7.3.1. Key Trends & Growth Drivers
12.6.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4. North Africa Neurodegenerative Disease Treatment Market
12.6.7.4.1. Key Trends & Growth Drivers
12.6.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5. South Africa Neurodegenerative Disease Treatment Market
12.6.7.5.1. Key Trends & Growth Drivers
12.6.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6. Rest of Middle East & Africa Neurodegenerative Disease Treatment Market
12.6.7.6.1. Key Trends & Growth Drivers
12.6.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

13. Company Profile

13.1. Market Share of Key Players in Neurodegenerative Disease Treatment Market
13.1.1. Novartis AG
13.1.1.1. Company Overview
13.1.1.2. Product Offered
13.1.1.3. Business Strategy
13.1.1.4. Financials
13.1.1.5. SWOT Analysis
13.1.1.6. Market Share Analysis
13.1.1.7. Key Achievements & Developments
13.1.2. Pfizer Inc.
13.1.2.1. Company Overview
13.1.2.2. Product Offered
13.1.2.3. Business Strategy
13.1.2.4. Financials
13.1.2.5. SWOT Analysis
13.1.2.6. Market Share Analysis
13.1.2.7. Key Achievements & Developments
13.1.3. Merck Serono
13.1.3.1. Company Overview
13.1.3.2. Product Offered
13.1.3.3. Business Strategy
13.1.3.4. Financials
13.1.3.5. SWOT Analysis
13.1.3.6. Market Share Analysis
13.1.3.7. Key Achievements & Developments
13.1.4. Biogen Inc.
13.1.4.1. Company Overview
13.1.4.2. Product Offered
13.1.4.3. Business Strategy
13.1.4.4. Financials
13.1.4.5. SWOT Analysis
13.1.4.6. Market Share Analysis
13.1.4.7. Key Achievements & Developments
13.1.5. Teva Pharmaceutical Industries Ltd.
13.1.5.1. Company Overview
13.1.5.2. Product Offered
13.1.5.3. Business Strategy
13.1.5.4. Financials
13.1.5.5. SWOT Analysis
13.1.5.6. Market Share Analysis
13.1.5.7. Key Achievements & Developments
13.1.6. UCB
13.1.6.1. Company Overview
13.1.6.2. Product Offered
13.1.6.3. Business Strategy
13.1.6.4. Financials
13.1.6.5. SWOT Analysis
13.1.6.6. Market Share Analysis
13.1.6.7. Key Achievements & Developments
13.1.7. C.H. Boehringer Sohn AG & Ko. KG
13.1.7.1. Company Overview
13.1.7.2. Product Offered
13.1.7.3. Business Strategy
13.1.7.4. Financials
13.1.7.5. SWOT Analysis
13.1.7.6. Market Share Analysis
13.1.7.7. Key Achievements & Developments
13.1.8. Sanofi S.A.
13.1.8.1. Company Overview
13.1.8.2. Product Offered
13.1.8.3. Business Strategy
13.1.8.4. Financials
13.1.8.5. SWOT Analysis
13.1.8.6. Market Share Analysis
13.1.8.7. Key Achievements & Developments
13.1.9. GlaxoSmithKline
13.1.9.1. Company Overview
13.1.9.2. Product Offered
13.1.9.3. Business Strategy
13.1.9.4. Financials
13.1.9.5. SWOT Analysis
13.1.9.6. Market Share Analysis
13.1.9.7. Key Achievements & Developments
13.1.10. Neuro-Hitech Inc.
13.1.10.1. Company Overview
13.1.10.2. Product Offered
13.1.10.3. Business Strategy
13.1.10.4. Financials
13.1.10.5. SWOT Analysis
13.1.10.6. Market Share Analysis
13.1.10.7. Key Achievements & Developments
13.1.11. Other Prominent Players

14. Disclaimer

Select License Type
  • Single User License $3750 USD
  • Multi-User License $475 USD
  • Corporate User License $5750 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients